Insilico’s AI-driven workflow to discover PHD inhibitors powered by chemistry42 generative platform
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.